Almost 20 years’ worth of follow-up in an international registry shows that patients with degenerative mitral regurgitation who underwent mitral valve (MV) repair had better survival, fewer ...

The findings provide contemporary surgical benchmarks, which will become even more important as M-TEER trial data emerge.

Polares Medical has secured $50m through a Series C financing round to further support the development of its novel cardiac ...

Mitral valve surgery is used to treat both primary and secondary MR. Surgery, whether mitral valve repair or replacement, has been the standard of care in treating patients with primary (degenerative) ...

Dear Mayo Clinic: Is minimally invasive heart surgery to repair a mitral valve a safer option than open-heart surgery? Is it common for a surgeon to have to switch to an open-heart procedure after ...

Patients who underwent mitral valve replacement had a more than threefold higher 10-year rate of infective endocarditis than those at moderate risk for the disease, whereas undergoing mitral valve ...

Surgery is thought to be life-saving for people who have ischemic mitral regurgitation, but it is unknown whether surgical repair or surgical replacement of the mitral valve is the better procedure.

Edwards Lifesciences has bought Harpoon Medical in a $250 million deal. The takeover rounds out Edwards’ pitch for the transcatheter mitral valve disease market by giving it control of a technology to ...

Overview The global Transcatheter Mitral Valve Replacement (TMVR) market is witnessing rapid expansion and is expected to grow at a strong CAGR of nearly 20% during the forecast period. The increasing ...